Podocyte injury damages podocytes in chimeric organoids. [PDF]
Udagawa T +3 more
europepmc +1 more source
aspA promoter as a tumor microenvironment-responsive autoswitch for anticancer agent expression in Escherichia coli. [PDF]
Lee D, Hong S, Kim J, Song M, Lim D.
europepmc +1 more source
A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma. [PDF]
Chen S +15 more
europepmc +1 more source
Correction: Antibody-drug conjugates in cancer therapy: current advances and prospects for breakthroughs. [PDF]
Wu D, Yang K, He R, Yin R, Shui L.
europepmc +1 more source
USP40 protects podocytes by deubiquitylating integrin β1. [PDF]
Mikami N +16 more
europepmc +1 more source
Antimetabolites synergize with non-genotoxic antibody drug conjugate conditioning in hematopoietic stem cell lentiviral gene therapy. [PDF]
Okalova J +10 more
europepmc +1 more source
Enhanced Antitumor Efficacy of a Combination of Immunotoxin and Photosensitizer Under Illumination in Xenograft Mice. [PDF]
Hamakubo S +9 more
europepmc +1 more source
An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin. [PDF]
Narbona J +5 more
europepmc +1 more source
GPA33-Targeted Trimeric Immunotoxin Exhibits Enhanced Antitumor Activity in Human Colorectal Cancer Xenografts. [PDF]
Ruiz-de-la-Herrán J +4 more
europepmc +1 more source
Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies. [PDF]
Xiao Z +15 more
europepmc +1 more source

